Advertisement

Problems in Genetic Screening which Confront the Law

  • Harvey L. Levy

Abstract

Before outlining those aspects of genetic screening that may confront established and accepted modes of medical behavior as well as actual laws, it is important to review genetic screening as it is currently practiced and as it has arisen. This discussion will be confined to that screening for genetic disorders conducted routinely either on a specific age group (such as newborns) within an entire population or on a certain ethnic segment of a population. In fact, it is this type of “wholesale” testing that is usually considered to be genetic screening rather than the original type of selective testing for genetic disorders that is confined to small groups of individuals, such as those in schools for the mentally retarded or those who are admitted to hospitals.

Keywords

Genetic Screening Acid Disorder Bacterial Assay Orotic Aciduria Sachs Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Guthrie, R. and Susi, A., A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants, Pediatrics 32: 338 (1963).Google Scholar
  2. 2.
    Levy, H.L., Genetic screening, in “Advances in Human Genetics” (Harris, H. and Hirschhorn, K., eds.), Vol. 4, pp. 1–104, 389–394, Plenum Press, New York (1973).Google Scholar
  3. 3.
    Smith, I. and Wolff, O.H., Natural history of phenylketonuria and influence of early treatment, Lancet 2: 540 (1974).CrossRefGoogle Scholar
  4. 4.
    Guthrie, R., Mass screening for genetic disease, Hospital Practice, June 1972, pp. 93–100.Google Scholar
  5. 5.
    Efron, M.L., Young, D., Moser, H.W. et al, A simple chromatographic screening test for the detection of disorders of amino acid metabolism, New Eng. J. Med. 270: 1378 (1964).CrossRefGoogle Scholar
  6. 6.
    Levy, H.L., Shih, V.E., Madigan, P.M. et al, Results of a screening method for free amino acids. I. Whole blood, II. Urine, Clin. Biochem. 1: 200, 208 (1968).Google Scholar
  7. 7.
    Beutler, E. and Blauda, M.C., A simple spot screening test for galactosemia, J. Lab. Clin. Med. 68: 137 (1966).Google Scholar
  8. 8.
    Beutler, E., A series of new screening procedures for pyruvate kinase deficiency, glucose-6-phosphate dehydrogenase deficiency, and glutathione reductase deficiency, Blood 28: 553 (1966).Google Scholar
  9. 9.
    Murphey, W.H., Patchen, L. and Guthrie, R., Screening tests for argininosuccinic aciduria, orotic aciduria, and other inherited enzyme deficiencies using dried blood specimens, Biochem. Genet. 6: 51 (1972).CrossRefGoogle Scholar
  10. 10.
    Garrick, M.D., Dembure, P., and Guthrie, R., Sickle-cell anemia and other hemoglobinopathies, New Eng. J. Med. 288: 1265 (1973).CrossRefGoogle Scholar
  11. 11.
    Kaback, M.M. and Zeiger, R.S., Heterozygote detection in Tay-Sachs disease: a prototype community screening program in the prevention of recessive genetic disorders in “Sphingolipids, Sphingolipidoses and Allied Disorders”(Volk, B.W. and Aronson, S.M., Eds.), p. 613, Plenum Press, New York (1972).Google Scholar
  12. 12.
    United States Department of Health, Education, and Welfare, Public Health Service, Health Services and Mental Health Administration (Maternal and Child Health Service). State Laws Pertaining to Phenylketonuria as of November 1970, U.S. Government Printing Office, Washington (1971).Google Scholar

Copyright information

© Plenum Press, New York 1976

Authors and Affiliations

  • Harvey L. Levy
    • 1
    • 2
    • 3
  1. 1.Massachusetts Dept. Public HealthState Laboratory InstituteUSA
  2. 2.Neurology Service and the Joseph P. Kennedy, Jr. LaboratoriesMassachusetts General HospitalUSA
  3. 3.Department of NeurologyHarvard Medical SchoolUSA

Personalised recommendations